摘要
目的比较IL-13Rα2致敏的DC—CTL对人胶质瘤干细胞和普通胶质瘤细胞的体外杀伤效应。方法用神经干细胞无血清培养法培养出U251胶质瘤干细胞并进行免疫荧光鉴定,GM—CSF、IL-4体外诱导成树突状细胞(DCs),与人工合成的IL-13Rα2(345-354)多肽孵育后再激活T淋巴细胞,CFDA—SE/PI双荧光染料标记的流式细胞计数法检测其对U251胶质瘤干细胞和普通U251胶质瘤细胞的体外杀伤作用。结果IL-13Rα2(345-354)抗原肽致敏的Dc—CTL对U251胶质瘤干细胞的杀伤率为(18.59±1.42)%,高于未用抗原肽致敏的DC—CTL及CIK对胶质瘤干细胞的杀伤率,其杀伤率分别为(10.35±0.98)%和(7.15±0.58)%,差异具有统计学意义(P〈0.001)。同时,IL-13Rα2(345-354)抗原肽致敏的DC—CTL对U251胶质瘤干细胞的杀伤率也高于其对普通U251细胞(11.53±0.65)%的杀伤率(P=0.001)。结论IL-13Rα2(345-354)致敏的Dc—CTL在体外对胶质瘤干细胞具有杀伤作用,且杀伤率高于对普通的胶质瘤细胞。
Objective To compare the killing effect of IL-13Rα2 sensitized DC - CTL cells on human glioblastoma stem cells and ordinary glioblastoma cells in vitro. Methods Tumor sphere cells were isolated from glioma cell line U251 with serum -free incubation techniques which used to isolated normal neural stem cells, the immunofluorescence staining was employed to identify the glioma stem cells. Mononuclear cells generated from healthy HLA * A* 0201 + positive donors peripheral blood were separated using standard Ficoll -Hypaque gradient density centrifugation. Corresponsive DCS from PBMC were co - cultured in RPMI1640 with GM - CSF and IL -4, and then matured by the artificial IL-13Rα2(345-354) to stimulate autologous T cells. CFSE and PI iluorochrome stain assay was used for detecting the killing effect in vitro. Results The killing effect of IL-13Rα2 sensitized DC - CTL cells on human glioblastoma stem cells was ( 18. 59 ± 1.42) % , which was much higher than that of uselessIL-13Rα2(345-354) sensitized DC - CTL cells and CIK on glioblastoma stem cells. The killing effect was ( 10. 35 ± 0. 98 ) % and (7. 15 ± 0. 58 ) %, recepecively. There were statistically differences among them Meanwhile , the killing effect of IL-13Rα2 sensitized DC - CTL cells on human glioblastoma stem cells was also higher than that on the ordinary U251 cells ( 11.53 ± 0. 65) % ( P = 0. 001 ). Conclusions The IL-13Rα2(345-354)induced CTLs exhibited specific cytotoxic against U251 glioma stem cells and the killing rate was much higher than that of U251 ceils in vitro.
出处
《中华神经外科杂志》
CSCD
北大核心
2012年第5期490-494,共5页
Chinese Journal of Neurosurgery